Aardvark Therapeutics AARD
NASDAQ AARD
$6.14 +0.26 (+4.33%)
As of: Aug 21, 2026 · 10:33 AM EDT

Aardvark Therapeutics (AARD) Operating Income (2024 - 2026)

Aardvark Therapeutics (AARD) posted Operating Income of -$22.5 million for Q1 2026, down 20.1% sequentially from -$18.7 million in Q4 2025, and down 114.56% YoY from $154.3 million in Q1 2025.

Aardvark Therapeutics (AARD) Operating Income (2024 - 2026) Analysis & Trends

Aardvark Therapeutics has reported Operating Income for 3 years, with the latest figure at -$22.5 million in Q1 2026.

  • Quarterly Operating Income fell 114.56% year-over-year to -$22.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$74.7 million (down 140.38% YoY) and the FY2025 annual result came in at -$62.7 million, down 175.29% from the prior year.
  • Operating Income retreated to -$22.5 million in Q1 2026 per AARD's latest filing, from -$18.7 million in the prior quarter.
  • Over five years, Operating Income peaked at -$2.2 million in Q1 2024 and troughed at -$22.5 million in Q1 2026.
  • A 3-year average of -$12.0 million and a median of -$10.5 million in 2025 frame the typical range for Operating Income.
  • The widest YoY moves for Operating Income: up 97.93% in 2025, down 382.27% in 2025.
  • Over 3 years, Operating Income stood at -$9.4 million in 2024, then plunged by 97.93% to -$18.7 million in 2025, then fell by 20.1% to -$22.5 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered -$22.5 million, -$18.7 million, and -$17.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Vertex Pharmaceuticals 140.00 Bn 132.14 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 86.31 Bn 78.32 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 65.24 Bn 60.06 Bn 1.37 Bn 493.00 Mn
4 Moderna 62.41 Bn 57.27 Bn 52.00 Mn -815.00 Mn
5 BeOne Medicines 42.25 Bn 37.15 Bn 1.53 Bn 325.05 Mn
6 Alnylam Pharmaceuticals 31.18 Bn 27.88 Bn 992.69 Mn 231.44 Mn
7 BioNTech SE 28.93 Bn 10.54 Bn 668.28 Mn -375.75 Mn
8 Insmed 27.55 Bn 26.39 Bn 358.27 Mn -1.55 Mn
9 Royalty Pharma 27.28 Bn 26.44 Bn - 133.12 Mn
10 Aardvark Therapeutics 134.25 Mn 60.32 Mn - -15.08 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.08 Mn
Mar 31, 2026 -22.46 Mn
Dec 31, 2025 -18.70 Mn
Sep 30, 2025 -17.70 Mn
Jun 30, 2025 -15.85 Mn
Mar 31, 2025 -10.47 Mn
Dec 31, 2024 -9.45 Mn
Sep 30, 2024 -5.09 Mn
Jun 30, 2024 -6.07 Mn
Mar 31, 2024 -2.17 Mn